Get started
Author

Hirofumi Miyake

Observed names: H. Miyake, Miyake, Hirofumi
Institution: Tenri Hospital
Observed institution: Tenri Hospital
ORCID: 0000-0001-5655-6356
Observed ORCID: 0000-0001-5655-6356
OpenAlex ID: A5028970938
TAFRO syndrome with a fatal clinical course following BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccination: A case report
2022 · Maaya Yamada, Ryuichi Minoda Sada, et al. · Journal of Infection and Chemotherapy · 15
PDF
Efficacy and Safety of Cefmetazole for Bacteremia Caused by Extended-Spectrum β-Lactamase–Producing Enterobacterales vs Carbapenems: A Retrospective Study
2023 · Eriko Kashihara, Ryuichi Minoda Sada, et al. · Open Forum Infectious Diseases · 12
PDF
Prevalence and factors associated with polypharmacy among patients with rheumatoid arthritis: a single-centre, cross-sectional study
2023 · Hirofumi Miyake, Ryuichi Minoda Sada, et al. · Clinical Rheumatology · 11
Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study
2022 · Hirofumi Miyake, Ryuichi Minoda Sada, et al. · Modern Rheumatology · 11
Single-centre, cross-sectional study on the factors and reasons for non-vaccination among patients with rheumatoid arthritis
2023 · Hirofumi Miyake, Ryuichi Minoda Sada, et al. · Modern Rheumatology · 9
Lupus Aortitis Successfully Treated with Moderate-dose Glucocorticoids: A Case Report and Review of the Literature
2020 · Hiroyuki Akebo, Ryuichi Sada, et al. · Internal Medicine · 9
PDF
An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus
2024 · Atsushi Manabe, Ryuichi Minoda Sada, et al. · Scientific Reports · 7
PDF
Factors and Reasons for Non-vaccination among Patients with Systemic Lupus Erythematosus: A Single-centre, Cross-sectional Study
2022 · Hirofumi Miyake, Ryuichi Minoda Sada, et al. · Internal Medicine · 7
PDF
Long‐term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA‐associated vasculitis in multicenter REVEAL cohort study
2025 · Shogo Matsuda, Takuya Kotani, et al. · Journal of Internal Medicine · 5
PDF
Risk prediction model for relapse of anti-synthetase syndrome-associated interstitial lung disease in Japanese multicentre MYKO cohort study
2025 · Shogo Matsuda, Takuya Kotani, et al. · Lara D. Veeken · 5
Differences in Organ Damage Based on Age at Onset in Idiopathic Inflammatory Myopathies: A Retrospective Multicenter MYKO Study
2025 · Hideaki Tsuji, Yuki Aitani, et al. · Internal Medicine · 5
PDF
Safety of glucocorticoid dose reduction in microscopic polyangiitis: a multicentre REVEAL cohort study
2025 · Hirofumi Miyake, Takuya Kotani, et al. · Modern Rheumatology · 4
Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study
2025 · Hirofumi Miyake, Takashi Kida, et al. · Lara D. Veeken · 2
Validation of the MCK model for predicting outcomes in myopathy-associated interstitial lung disease: A multicentre MYKO cohort study
2025 · Hirofumi Miyake, Ran Nakashima, et al. · Modern Rheumatology · 2
The diagnostic utility of intima-media thickness measurement compared with the halo sign in temporal artery ultrasonography: a single-centre retrospective study
2024 · Kazuma Yoshida, Ryuichi M. Sada, et al. · Clinical and Experimental Rheumatology · 2
PDF
Reviving Sternheimer stain: A single-center retrospective study to detect the diagnostic utility of urinary tract infections in the emergency department
2024 · Hikaru Nagatomi, Ryuichi Minoda Sada, et al. · Journal of Infection and Chemotherapy · 2
PDF
Successful treatment of streptococcal toxic shock syndrome complicated by primary peritonitis and bilateral empyema in a healthy young woman: Identification of uncommon clone emm103 and novel sequence type 1363
2024 · Yoshihiko M. Sakaguchi, Koichiro Murakami, et al. · IDCases · 2
Giant Cell Arteritis as a Form of Pembrolizumab-Associated Vascular Toxicity
2026 · Daichi Umemoto, Hiroyuki Nagano, et al. · JACC Case Reports · 1
Renal outcomes in ANCA-associated vasculitis without clinically apparent kidney involvement: a multicentre REVEAL cohort study
2026 · Tomoki Taniguchi, Ryosuke Hiwa, et al. · Lara D. Veeken · 1
Rituximab versus intravenous cyclophosphamide for anti-neutrophil cytoplasmic antibody-associated vasculitis with severe renal impairment: A multicentre REVEAL cohort study
2025 · Hirofumi Miyake, Ayana Okazaki, et al. · Modern Rheumatology · 1
Histological subtypes of rheumatoid arthritis-associated lymphoproliferative disorders: Serological and Epstein–Barr virus findings
2025 · Keiichiro Kinoshita, Hirofumi Miyake, et al. · Modern Rheumatology · 1
PDF
The Impact of Early Optimization of Infliximab Blood Concentrations >1 μg/mL on Therapeutic Effectiveness in Rheumatoid Arthritis
2023 · Yuji Nozaki, Takuya Kotani, et al. · Frontiers in Bioscience-Landmark · 1
PDF
Elevated White Blood Cell Count and Lactate Dehydrogenase Levels Are Important Markers for Diagnosing Relapse of Adult-onset Still's Disease under Tocilizumab Use
2022 · Sho Matsushita, Kenei Sada, et al. · Internal Medicine · 1
PDF
Contrast-enhanced fluid-attenuated inversion recovery magnetic resonance imaging was useful in detecting inflammation of the meninges in neuropsychiatric systemic lupus erythematosus: a case report
2018 · Kazuto Tsukita, Hirofumi Miyake, et al. · Rinsho Shinkeigaku · 1
PDF
Organ damage profiles and associated factors in juvenile versus adult-onset SLE: a matched analysis from the Japanese ANSWER-SLE cohort
2026 · Shion Kachi, Hideaki Tsuji, et al. · Lara D. Veeken
Works count: 60
Citation count: 117
H-index: 7
I10-index: 4
Year
Topic
Type